Knowledge Complexity and Collaborative Organizational Activities on Clinical Trials by Foreign Biopharmaceutical Firms in China
High-technology companies, such as the pharmaceutical, are increasingly developing their technological advantages in foreign countries. For instance, China is one of the favored destinations for the global clinical trial activity. This article develops and tests the argument that operational knowledge complexity in clinical trials influences inter-firm collaboration between foreign industrial firms in China. Unlike a perceived link between complexity and internalization, we propose a link between knowledge complexity and joint activities. We also suggest that the joint activity becomes complex when it is not internalized. Therefore, there is a positive association between operational and structural complexity. Tested on four measures of complexity in the clinical trial, we confirm that as complexity increases, there is an increase in the propensity of the foreign firm to collaborate with another foreign firm in China. We discuss theoretical and practical implications for multiple perspectives.
Tariq Malik Yu Miao
both of Dongbei University of Finance & Economics.China
国际会议
2011 Academy for Global Business Advancement(AGBAs)8th World Congress(全球商务发展学会第八届国际会议)
大连
英文
495-516
2011-09-15（万方平台首次上网日期，不代表论文的发表时间）